Brief: Acorda TherapeuticsCourt Held Hearing To Consider Approval Of Sale Of Substantially All Of Co's Assets To Merz Pharmaceuticals Under Asset Sale
12/06/2024 22:37
* ACORDA THERAPEUTICS:COURT HELD HEARING TO CONSIDER
APPROVAL OF
SALE OF SUBSTANTIALLY ALL OF CO'S ASSETS TO MERZ PHARMACEUTICALS
UNDER ASSET SALE
* ACORDA THERAPEUTICS INC - COURT ENTERED AN ORDER ON JUNE
12,
2024 APPROVING ASSET SALE
Source text for Eikon: ID:n0000950170-24-072511
Further company coverage: [ ]
Recent news on Acorda Therapeutics
See all newsBrief: Acorda TherapeuticsCourt Held Hearing To Consider Approval Of Sale Of Substantially All Of Co's Assets To Merz Pharmaceuticals Under Asset Sale
Brief: Acorda Says Debtors Did Not Receive More Than One Qualified Bid Before Bid Deadline, In Connection With Chapter 11 Proceedings
Live Markets: Biotech companies in 'Darwinian' world as cash remains king
U.S. FDA declines to approve Supernus' drug-device combination for Parkinson's disease (updated)
U.S. FDA declines to approve Supernus' drug-device combination for Parkinson's disease